• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体内注射白细胞介素-1的命运:在肾脏中的隔离与降解

Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney.

作者信息

Poole S, Bird T A, Selkirk S, Gaines-Das R E, Choudry Y, Stephenson S L, Kenny A J, Saklatvaa J

机构信息

National Institute for Biological Standards and Control, Potters Bar, Herts, UK.

出版信息

Cytokine. 1990 Nov;2(6):416-22. doi: 10.1016/1043-4666(90)90050-4.

DOI:10.1016/1043-4666(90)90050-4
PMID:2104235
Abstract

The tissue distribution and route of clearance of human recombinant interleukin 1 alpha (IL 1 alpha) injected intravenously in rats was studied. The plasma half-life was approximately 2.5 min, and this was increased after nephrectomy, the kidney being the major organ through which the IL 1 alpha was excreted. Two iodinated fragments of IL 1 alpha, of approximately 5 and 9 kDa, were excreted by the kidneys whereas only intact, 17-kDa IL 1 alpha was detected in plasma, suggesting that the protein was being degraded after uptake by the kidney. The results of in vivo experiments in which surface endopeptidase-24.11 was inhibited with phosphoramidon and in vitro experiments in which rat kidney homogenates were incubated with radiolabeled IL 1 alpha suggest that the cytokine was endocytosed and then hydrolysed by lysosomal proteinases.

摘要

研究了静脉注射给大鼠的重组人白细胞介素1α(IL - 1α)的组织分布和清除途径。血浆半衰期约为2.5分钟,肾切除术后该半衰期延长,肾脏是IL - 1α排泄的主要器官。肾脏排泄出两个分子量约为5 kDa和9 kDa的IL - 1α碘化片段,而血浆中仅检测到完整的17 kDa的IL - 1α,这表明该蛋白在被肾脏摄取后发生降解。用磷酰胺抑制表面内肽酶 - 24.11的体内实验结果以及用放射性标记的IL - 1α孵育大鼠肾脏匀浆的体外实验结果表明,该细胞因子被内吞,然后被溶酶体蛋白酶水解。

相似文献

1
Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney.大鼠体内注射白细胞介素-1的命运:在肾脏中的隔离与降解
Cytokine. 1990 Nov;2(6):416-22. doi: 10.1016/1043-4666(90)90050-4.
2
The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats.人重组白细胞介素1β在正常大鼠体内的药代动力学、分布及降解
Scand J Immunol. 1991 Nov;34(5):597-610. doi: 10.1111/j.1365-3083.1991.tb01583.x.
3
Metabolic behavior and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1 beta.人白细胞介素-1β合成九肽片段163 - 171的代谢行为与分布
Lymphokine Res. 1990 Fall;9(3):371-9.
4
Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat.大鼠体内白细胞介素-6/肝细胞刺激因子的血浆清除率、器官分布及靶细胞
Eur J Biochem. 1988 Nov 1;177(2):357-61. doi: 10.1111/j.1432-1033.1988.tb14384.x.
5
D-mannose dimer introduced human recombinant interleukin- 1 alpha, NEO IL-1 alpha, exhibits altered tissue distribution in mice.
J Interferon Cytokine Res. 1996 Apr;16(4):333-6. doi: 10.1089/jir.1996.16.333.
6
Clearance and tissue distribution of recombinant human interleukin 1 beta in rats.重组人白细胞介素1β在大鼠体内的清除率及组织分布
Cancer Res. 1990 Sep 15;50(18):5751-5.
7
Fate of interleukin-6 in the rat. Involvement of skin in its catabolism.大鼠体内白细胞介素-6的命运。皮肤在其分解代谢中的作用。
Eur J Biochem. 1990 Apr 20;189(1):113-8. doi: 10.1111/j.1432-1033.1990.tb15466.x.
8
Systemic biodistribution of radioiodinated interleukin-2 in the rat.放射性碘化白细胞介素-2在大鼠体内的全身生物分布
J Biol Response Mod. 1989 Aug;8(4):375-84.
9
39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.39-kD蛋白在体内抑制组织型纤溶酶原激活物的清除。
J Clin Invest. 1993 Aug;92(2):937-44. doi: 10.1172/JCI116669.
10
Interleukin-1 receptors in mouse kidney: identification, localization, and modulation by lipopolysaccharide treatment.小鼠肾脏中的白细胞介素-1受体:脂多糖处理后的鉴定、定位及调节
Endocrinology. 1991 May;128(5):2618-24. doi: 10.1210/endo-128-5-2618.

引用本文的文献

1
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease.双重负担:探索慢性肾脏病中的心血管并发症。
Biomolecules. 2024 Oct 31;14(11):1393. doi: 10.3390/biom14111393.
2
Pharmacological functions of salidroside in renal diseases: facts and perspectives.红景天苷在肾脏疾病中的药理作用:现状与展望。
Front Pharmacol. 2024 Jan 8;14:1309598. doi: 10.3389/fphar.2023.1309598. eCollection 2023.
3
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
慢性肾脏病的心血管并发症:来自欧洲肾脏病协会的欧洲肾脏和心血管医学工作组的综述。
Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083.
4
Profile of Urinary Cytokines in Kawasaki Disease: Non-Invasive Markers.川崎病患者尿细胞因子谱:非侵入性标志物
Diagnostics (Basel). 2021 Oct 8;11(10):1857. doi: 10.3390/diagnostics11101857.
5
Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease.慢性肾脏病患者的低血红蛋白水平与银屑病风险增加。
Sci Rep. 2021 Jul 20;11(1):14741. doi: 10.1038/s41598-021-94165-w.
6
The Influence of Inflammation on Anemia in CKD Patients.炎症对慢性肾脏病患者贫血的影响。
Int J Mol Sci. 2020 Jan 22;21(3):725. doi: 10.3390/ijms21030725.
7
Predicting hepcidin level using inflammation markers and iron indicators in patients with anemia of chronic disease.使用炎症标志物和铁指标预测慢性病贫血患者的铁调素水平。
Hematol Transfus Cell Ther. 2019 Oct-Dec;41(4):342-348. doi: 10.1016/j.htct.2019.03.011. Epub 2019 Jul 23.
8
Mechanisms of haemolysis-induced kidney injury.溶血导致肾损伤的机制。
Nat Rev Nephrol. 2019 Nov;15(11):671-692. doi: 10.1038/s41581-019-0181-0. Epub 2019 Aug 27.
9
Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?增量透析以保留残余肾功能——开始透析时是否有一种通用的方法?
Semin Dial. 2018 Jul;31(4):343-352. doi: 10.1111/sdi.12701. Epub 2018 May 7.
10
Preservation of residual kidney function in hemodialysis patients: reviving an old concept.维持血液透析患者的残余肾功能:重拾一个古老的概念。
Kidney Int. 2016 Aug;90(2):262-271. doi: 10.1016/j.kint.2016.02.037. Epub 2016 May 12.